As reported by the field clinical specialist (fcs), during a transfemoral tavr procedure with a 23mm sapien 3 valve, the valve was not correctly aligned on the balloon, and it was inflated asymmetrically, leading to a valve low position of 30/70 (aortic/ventricular).There was no additional actions taken at the time of the procedure.
|
Correction to h6 based on additional information.The device was not returned to edwards lifesciences for evaluation.Due to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.The ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.In this case, the reported event of the valve not being between the alignment markers and deployed was unable to be confirmed due to the device or appropriate imagery not being returned/provided.Per the event description, the valve was not between the alignment markers prior to valve deployment.If the crimped valve was not within the internal shoulders prior to deployment, the deployed valve could be inflated asymmetrically, and thus, pushed towards aorta and/or left ventricle during the deployment, leading to the reported low valve positioning (30/70).Per the training manual, 'slowly rotate the fine adjustment wheel towards you to center the thv exactly between the valve alignment markers with no gap or overlap'.'check to ensure: thv is exactly between the valve alignment markers'.As such, available information suggests that use error (not following ifu/training manual) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
|